You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

 

Online download statistics by month:

Online download statistics by month: January 2022 to September 2024

AbstractFullPdf
Jan 2022475490111
Feb 2022307309105
Mar 202218819181
Apr 202216617141
May 202215616258
Jun 202213413934
Jul 202213313953
Aug 202215515546
Sep 202213813968
Oct 202213718657
Nov 202211211328
Dec 202212012234
Jan 202310110238
Feb 202312913042
Mar 2023939352
Apr 2023727235
May 2023797928
Jun 202311211237
Jul 2023797936
Aug 202311411430
Sep 2023808034
Oct 2023848431
Nov 2023989827
Dec 2023899036
Jan 2024848832
Feb 2024626237
Mar 2024697192
Apr 2024889058
May 2024747532
Jun 2024677146
Jul 2024899035
Aug 2024636121
Sep 2024848438
Total403141411533